Wanting Niu

Dr. Wanting Niu

STEM, Regis College, Weston, Connecticut, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Biomaterials
Verified
Journal Article
Closed access
YMYuan-Huan Ma
Yuan-Huan Ma
HSHui-Juan Shi
Hui-Juan Shi
QWQing-Shuai Wei
Qing-Shuai Wei
QDQing-Wen Deng
Qing-Wen Deng
JSJia-Hui Sun
Jia-Hui Sun
Xiang ZengXiang Zeng
Xiang Zeng

12 April 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
MLMing Li
Ming Li
YWYing Wang
Ying Wang
LCLiang Cheng
Liang Cheng
Wanting NiuWanting Niu
Wanting Niu
GZGuoan Zhao
Guoan Zhao
RBRenge Bu
Renge Bu
Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications

1 September 2020 in Stroke
Verified
Journal Article
Closed access
PDF file
SCSu Jing Chan
Su Jing Chan
EEElga Esposito
Elga Esposito
Kazuhide HayakawaKazuhide Hayakawa
Kazuhide Hayakawa
EMEmiri Mandaville
Emiri Mandaville
RSRaymond A.A. Smith
Raymond A.A. Smith
VNVictor Nurcombe
Victor Nurcombe
Background and Purpose: Although VEGF 165 (vascular endothelial growth factor-165) is able to enhance both angiogenesis and neurogenesis, it also increases vascular permeability through the blood-brain barrier. Heparan sulfate (HS) sugars play important roles in regulating VEGF bioactivity in the pericellular compartment. Here we asked whether an affinity-purified VEGF 165 -binding HS (HS7) could augment endogenous VEGF activity during stroke recovery without affecting blood-brain barrier function. Methods: Both rat brain endothelial cell line 4 and primary rat neural progenitor cells were used to evaluate the potential angiogenic and neurogenic effects of HS7 in vitro. For in vivo experiments, male Sprague-Dawley rats were subjected to 100 minutes of transient focal cerebral ischemia, then treated after 4 days with either PBS or HS7. One week later, infarct volume, behavioral sequelae, immunohistochemical markers of angiogenesis and neural stem cell proliferation were assessed. Results: HS7 significantly enhanced VEGF 165 -mediated angiogenesis in rat brain endothelial cell line 4 brain endothelial cells, and increased the proliferation and differentiation of primary neural progenitor cells, both via the VEGFR2 (vascular endothelial growth factor receptor 2) pathway. Intracerebroventricular injection of HS7 improved neurological outcome in ischemic rats without changing infarct volumes. Immunostaining of the compromised cerebrum demonstrated increases in collagen IV/Ki67 and nestin/Ki67 after HS7 exposure, consistent with its ability to promote angiogenesis and neurogenesis, without compromising blood-brain barrier integrity. Conclusions: A VEGF-activating glycosaminoglycan sugar, by itself, is able to enhance endogenous VEGF 165 activity during the post-ischemic recovery phase of stroke.

8 November 2017 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
LALuiz Felipe Ambra
Luiz Felipe Ambra
LGLaura de Girolamo
Laura de Girolamo
Wanting NiuWanting Niu
Wanting Niu
APAmy Phan
Amy Phan
MSMyron Spector
Myron Spector
AGAndreas H. Gomoll
Andreas H. Gomoll

4 September 2019 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
SCSu Jing Chan
Su Jing Chan
Wanting NiuWanting Niu
Wanting Niu
KHKazuhide Hayakawa
Kazuhide Hayakawa
GHGen Hamanaka
Gen Hamanaka
XWXiaoying Wang
Xiaoying Wang
ELEng Lo
Eng Lo
Biomaterials provide novel platforms to deliver stem cell and growth factor therapies for central nervous system (CNS) repair. The majority of these approaches have focused on the promotion of neural progenitor cells and neurogenesis. However, it is now increasingly recognized that glial responses are critical for recovery in the entire neurovascular unit. In this study, we investigated the cellular effects of epidermal growth factor (EGF) containing hydrogels on primary astrocyte cultures. Both EGF alone and EGF‐hydrogel equally promoted astrocyte proliferation, but EGF‐hydrogels further enhanced astrocyte activation, as evidenced by a significantly elevated Glial fibrillary acidic protein (GFAP) gene expression. Thereafter, conditioned media from astrocytes activated by EGF‐hydrogel protected neurons against injury and promoted synaptic plasticity after oxygen–glucose deprivation. Taken together, these findings suggest that EGF‐hydrogels can shift astrocytes into neuro‐supportive phenotypes. Consistent with this idea, quantitative‐polymerase chain reaction (qPCR) demonstrated that EGF‐hydrogels shifted astrocytes in part by downregulating potentially negative A1‐like genes (Fbln5 and Rt1‐S3) and upregulating potentially beneficial A2‐like genes (Clcf1, Tgm1, and Ptgs2). Further studies are warranted to explore the idea of using biomaterials to modify astrocyte behavior and thus indirectly augment neuroprotection and neuroplasticity in the context of stem cell and growth factor therapies for the CNS. Stem Cells Translational Medicine 2019

27 March 2019 in Cell Transplantation
Verified
Journal Article
Open access
PDF file
JPJeayoung Park
Jeayoung Park
PBPetr Baranov
Petr Baranov
AAAybike Aydin
Aybike Aydin
HAHany Abdelgawad
Hany Abdelgawad
DSDeepti Singh
Deepti Singh
MYMichael J. Young
Michael J. Young
One of the current limitations of retinal transplantation of stem cells as well as other cell types is the dispersion of cells from the injection site (including loss of cells into the vitreous chamber) and low survival after transplantation. Gelatin-hydroxyphenyl propionic acid (Gtn-HPA) conjugate is a biodegradable polymer that can undergo covalent cross-linking in situ , allowing for injection of incorporated cells through a small caliber needle followed by gel formation in vivo . We tested the hypothesis that Gtn-HPA hydrogel supports survival and integration of retinal progenitor cells (RPCs) post-transplantation. In vitro compatibility and in vivo graft survival were assessed by mixing an equal volume of Gtn-HPA conjugate and RPC suspension and triggering enzyme-mediated gelation, using minute amounts of horseradish peroxidase and peroxide. Immunocytochemistry showed >80% survival of cells and minimal apoptosis for cells incorporated into Gtn-HPA, equivalent to controls grown on fibronectin-coated flasks. RPCs undergoing mitosis were seen within the three-dimensional Gtn-HPA hydrogel, but the percentage of Ki-67-positive cells was lower compared with the monolayer controls. For in vivo studies, gel–cell mixture or cell suspension in saline was trans-sclerally injected into the left eye of female Long Evans rats immunosuppressed with cyclosporine A. Grafts survived at the 1 week time point of the study, with Gtn-HPA-delivered grafts showing less inflammatory response demonstrated by anti-leukocyte staining. More eyes in the gel–cell mixture group showed surviving cells in the subretinal space compared with saline-delivered controls, while the number of cells surviving per graft was not significantly different between the two groups. This work demonstrates an injectable in situ cross-linking hydrogel as a potential vehicle for stem cell delivery in the retina.